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Abstract 
Introduction and Objective: Medication-related osteonecrosis of 
the jaw (MRONJ) is a recently described adverse effect associated 
with anti-resorptive and anti-angiogenic agents. The objective of 
this article is to report a case of MRONJ treated surgically using a 
ultrasonic device (piezosurgery). Case report: A 66 year-old female 
being treated with a bisphosphonate (alendronate) for more than 4 
years developed MRONJ of the lower jaw after dental extraction. 
Two debridement attempts of necrotic bone tissue and primary 
intention closure with conventional techniques were performed, 
without success. Finally, treatment with antibiotics and piezosurgery 
leaded to disease remission. Conclusion: Even though more studies 
are needed to create a protocol that might include this therapeutic 
modality, specially when there was no success with conservative 
management or conventional treatment techniques, the use of 








The Bisphosphonate-Associated Osteonecrosis of 
the Jaw (BRONJ) was described at first by Marx in 
2003 [5], since then, the number of reports of this 
complication is growing. Recently, its denomination 
was changed to Medication-Related Osteonecrosis of 
the Jaw (MRONJ), due to a higher number of cases 
involving other antiresorptive and antiangiogenic 
medicines, such as denosumab [13]. 
Bisphosphonates (BP) are inhibitors of 
osteoclasts, which are cells that have a fundamental 
action in reducing bone resorption. BPs have in 
their chemical composition two phosphorus atoms 
connected to a carbon atom. This structure confers 
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resistance to enzymatic hydrolysis and allows 
for fixation of this medicine to hydroxyapatite 
crystals and connection to the bone surface [6]. 
Intravenous bisphosphonates (BP IV) are indicated 
in the management of conditions related to cancer, 
such as hypercalcemia, metastasis associated to 
breast, prostate and lung tumors, multiple myeloma 
and, in some circumstances, osteoporosis. Oral 
bisphosphonates (oral BP) are used clinically 
for osteoporosis, osteopenia, Paget’s disease and 
osteogenesis imperfecta [13].
The incidence of MRONJ in studies of the 
American Association of Oral and Maxillofacial 
Surgeons (AAOMS) published in 2014 shows that 
patients with cancer who use zolendronate, a 
formulation of BP IV, have a risk of 1% of developing 
MRONJ, which means 50 to 100 times higher than 
placebo. Patients with osteoporosis and oral BP use 
for more than 4 years have a risk of MRONJ of 
0.1% - 0.21%. Thus, the risk of developing MRONJ 
in patients exposed to BP for the treatment of 
osteoporosis is about 100 times lower than that 
for patients receiving the medication for cancer 
treatment. The mean time of BP use in patients 
diagnosed with MRONJ was 4.4 years [13]. 
The pathophysiology is not totally elucidated 
yet. Some hypothesis that try to explain the unique 
localization of the MRONJ in the jaws include altered 
remodeling and resorption, angiogenesis inhibition, 
constant microtrauma, suppression of innate or 
acquired immunity, vitamin D deficiency, soft tissue 
toxicity, inflammation and infection [13]. In other 
words, the selective accumulation of BP in the jaws 
associated with a specially high bone turnover 
in these bones and the continuous exposition of 
them to the external environment through dental 
involvement, due to frequent and recurrent dental 
infections, which could contiguously affect the 
maxillaries, leading to local tissue acidosis possibly 
acting as a trigger for MRONJ [15].
Diagnosis of MRONJ can be made if the 
following characteristics are present in a patient: 1) 
current or previous treatment with antiresorptive 
or antiangiogenic medication; 2) exposed bone or 
bone that can be probed through an intraoral or 
extraoral fistula in the maxillofacial region that has 
persisted for eight weeks or more; 3) no history 
of radiation exposure or metastatic disease in the 
jaws [13]. The radiographic aspect can be defined 
as: diffuse bone sclerosis, presence of sequestration, 
periosteal reaction and oro-antral fistula, such as 
diffuse radiolucent areas [11]. The median age of 
patients that develop MRONJ is 70 years old (38 
to 88 years old) [7].
Treatment is based on disease staging and 
varies from conservative hygiene measures, 
symptomatics, antibiotics and surgery. When a more 
invasive treatment is indicated, the manipulation 
of bone tissue is pursued in a more conservative 
fashion, with the realization of minimally traumatic 
osteotomies. In this context, the debridement or 
resection performed with piezosurgery (ultrasonic 
device) is an option of treatment which presents 
advantages such as its antibacterial effect [1], less 
trauma, less bleeding (trans and postoperative) and 
a selective cut of only bone tissue [10].
This article aims to report a MRONJ case after 
tooth extraction in a patient using oral BP, treated 
with piezosurgery.
Case report
Patient AGS, 66 year-old female, had as 
chief complaint that she didn’t achieve adequate 
healing after dental extraction. It was observed 
that her dental alveolus did not heal 1 year 
after the extraction of tooth 37 (mandibular left 
second molar). In her past medical history, she 
was found to have depression, systemic arterial 
hypertension, hypothyroidism, osteoporosis and 
rheumatoid arthritis for which she was making use 
of anti-hypertensives, diuretics, antidepressants, 
anti-acids and treatment for hypothyroidism. She 
had already been submitted to a dental abscess 
drainage in the same region of the tooth extraction 
and two debridement attempts of the extraction 
site with closing by first intention. However, those 
interventions were unsuccessful and progressed 
to the loss of another elements: 36 (mandibular 
left first molar), 33 (mandibular left canine), 32 
(mandibular left lateral incisor), 31 (mandibular left 
central incisor) and 41 (mandibular right central 
incisor). Since, at first, her condition was considered 
to be osteomyelitis, she had undergone antibiotic 
therapy with intravenous ceftriaxone 1 gram per 
day, substituted for clindamycin 600mg three times 
a day, and finally, ciprofloxacin 1 gram twice a 
day to be administrated orally, coming to a total 
of 30 days of antibiotic therapy. After the failure 
of the above treatment, our Oral and maxillofacial 
surgery team was consulted and it was noticed that 
she made use of alendronic acid and prednisone 
for over four years for treatment of osteoporosis 
and rheumatoid arthritis under a rheumatologist’s 
supervision. During inspection of the oral cavity, 
there was an area of necrotic bone tissue exposed in 
the body of the left mandible on the alveolar crest, 
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an active vestibular fistula in the region of the 33 
(mandibular left canine) with purulent drainage 
to manipulation (figure 1). Because the patient 
did not have a radiotherapy or metastatic disease 
history, the diagnosis of osteonecrosis of the jaw 
(MRONJ) was concluded, due to alendronate use. In 
the image obtained by a panoramic radiography, it 
could be noticed the alveolus of the 37 (mandibular 
left second molar) tooth and an alteration of bone 
density in the anterior region of the jaw (figure 2). 
From the diagnosis confirmation and contact with 
the rheumatologist, alendronate was suspended. 
The plan of treatment involved a surgical procedure 
under general anesthesia for the performance of an 
alveoloplasty, aiming for the removal of necrotic 
bone and closure of the wound by primary intention, 
with extraction of the last present teeth on the right 
mandibular region. The osteotomies were performed 
totally with piezosurgery (figure 3). The wound 
closure was performed in two layers. First, deeper 
tissue suture with a polyglactin 910 thread, with 
simple stitches interrupted in “U”, which promoted 
the eversion of the wound borders, followed by a 
superficial layer of suture with interrupted simple 
stitches, in order to grasp the margins of the wound 
better (figure 4). The patient was discharged from the 
hospital in the following morning, with prescribed 
antibiotic therapy for 30 days (amoxicillin 500mg 
1 capsule every 8 hours), besides analgesic and 
anti-inflammatory medications. Surgical wound 
care involved oral hygiene with careful brushing of 
the superior dental arch and tongue, associated to 
the use of chlorhexidine 0.12%, twice a day since 
the third postoperative day. Postoperative consults 
happened after day 7, 14, 21 and 30, and, after that 
period, postoperative control was monthly. During 
this period, in which the patient remained with 
occluded wounds, it was observed an absence of 
fistulae and signs or symptoms of infection. In a 
panoramic radiograph of 16 months postoperatively, 
the bone aspect was consistent with normality with 
the mandible totally edentulous and the alveolar 
ridge regularized, preventing, then, trauma by the 
use of total prosthesis (figures 5 and 6). After 24 
months, new regions of bone exposure or fistulae 
presence were not observed.
Figure 1 – Initial aspect, we observed a necrotic bone 
exposure in the region of tooth 37 (mandibular left 
second molar)
Figure 2 – Initial radiographic image, with bone 
exposure and bone density alterations in the right 
anterior mandibular region
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Figure 3 – Bone fragment corresponding to the residual 
alveolar process involved and the teeth extracted
Figure 4 – Immediate postoperative. Closure of the 
borders was performed by primary intention and with 
no excessive tension
Figure 5 – 16 month postoperative follow-up, with an 
aspect that shows appropriate tissue repair
Figure 6 – Panoramic radiography at 16 months 
postoperative
Discussion
In the current article, it was presented a 
MRONJ case in a 66 year-old female, after having 
performed a dental extraction and using oral BP for 
osteoporosis probably related to rheumatoid arthritis 
and its treatment (corticosteroids). The epidemiology 
of our case was consistent with a very relevant 
study found in the literature. Franco et al. [3] with 
203 patients diagnosed with MRONJ, showed that 
approximately 75% of patients were female, with a 
mean age of 67.8 years old. Although, in opposition 
to our report, 71% of the patients administrated BP 
for oncologic treatment and 77.34% receiving the 
medicine by parenteral administration. As of our 
MRONJ case, predilection for the jaw compared to 
the maxilla (1.8:1) was observed, and the dental 
extraction was the most common associated factor. 
Another important factor to be considered, 
is that the patient of the report has rheumatoid 
arthritis and was using daily corticoids for 
more than 5 years. According to the literature, 
corticoids administred in high doses interact with 
cell groups involved in the bone turnover process, 
such as osteoclasts, osteoblasts and osteocytes, 
stimulating the resorption process and inhibiting 
bone formation. As a result of these alterations, in 
each cycle of bone remodeling, around 30% less 
of bone tissue is produced in comparison to the 
normal conditions [14]. We believe that the use of 
a corticosteroid contribute to MRONJ development.
Risk factors such as duration of use of 
bisphosphonates, use of steroids, advanced age, 
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diabetes, suppressed markers of bone turnover, genetic factors, local factors, oral surgeries, anatomic 
location and concomitant oral diseases are also mentioned in the consensus of the Korean Association 
of Oral and Maxillofacial Surgeon [7].
The staging and proposed treatment for each stage of MRONJ are summarized in the table I [13].
Table I – MRONJ staging and treatment
Stage Diagnosis Treatment
Patients at risk
Asymptomatic and with no apparent 
necrotic bone, but who received oral 
BP or IV treatment.
No treatment, but patients must be 
informed about the symptoms and 
risk of developing MRONJ.
Stage 0
Patients who do not present necrotic 
bone,  but  present  non-speci f ic 
symptoms, clinical or radiographic
findings*.
Symptomatic treatment. Analgesics 
and antibiotics when necessary. 
These patients must be monitored 
closely.
Stage 1
Exposed and necrotic bone or fistula 
which probes to bone in asymptomatic 
patients and no evidence of infection. 
They can present with radiographic 
findings mentioned in stage 0.
No treatment is needed, only 
informing patients and reviewing 
the indication of BPs. Consider using 
oral topical chlorhexidine 0.12%.
Stage 2
Exposed and necrotic bone or fistula 
which probes to the bone with evidence 
of infection. Usually symptomatic 
patients. They can also present with 
the radiographic findings mentioned 
in stage 0.
Symptomat ic  t reatment  w ith 
antibiotics, analgesics and rinses. 
Debridement** to alleviate the 
irritation of the soft tissues area 
and infection control.
Stage 3
Exposed and necrotic bone or fistula 
which probes to the bone with evidence 
of infect ion and one or more of 
additional characteristics***.
Debridement including resection in 
conjunction with antibiotic therapy, 
palliative treatment with resolution 
of the acute infection and pain.  
* Unexplained toothache; acute pain in the body of the mandible which can radiate to the TMJ; sinus pain that can be associated 
with inflammation and increase in the maxillary sinus wall; alteration of neurosensory function. 
Clinical findings: Dental loss not caused by chronic periodontal disease; periapical/periodontal fistula which is not related to 
caries or pulpal necrosis; 
Radiographic findings: alveolar bone loss or resorption not caused by chronic periodontal disease; modification in the trabecular 
pattern - dense woven bone and persistence of unremodeled bone in extraction areas; regions of osteosclerosis involving the 
alveolar bone and the enclosing basilar bone; increase of the periodontal ligament thickness (thickening of the lamina dura and 
decreased size of the periodontal ligament space). 
** Independent of disease stage, bone sequesters should be removed to ease the repair of soft tissue. Teeth extraction when 
exposed and necrotic bone is present must be considered, because the extraction is unlikely to exacerbate the necrotic process 
established. 
*** Exposed necrotic bone expanding beyond the alveolar bone region; pathologic fracture; extra-oral fistula; oral antral 
communication; osteolysis extending to the inferior border of the mandible or sinus floor.
As this patient fits in stage 2 of MRONJ (table I), 
the AAOMS’s recommendation includes symptomatic 
treatment with antibiotics, analgesics, rinses and 
debridement to relieve the irritation of soft tissue and 
infection control. In our patient’s case, considering 
the clinical aspects of the lesion, the interdental 
crest already exposed, anterior extension on the 
lingual region and necessity of regularization of the 
ridge for a subsequently adaptation of prosthesis, 
an alveolectomy was performed. 
Before our consultation, two surgical procedures 
were performed to remove the necrotic bone tissue 
and close the wound without success. We believe 
that the failure of these procedures may have 
happened due to the use of rotating instruments, 
which promote t issue warming, besides the 
antibiotic therapy for a short period and alendronate 
maintenance in the course of the disease.
In the reported case, due to the need to reduce 
surgical trauma and not having a definite protocol 
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for the debridement and resection, piezosurgery was 
chosen. Furthermore, conventional techniques have 
already been tried in two previous procedures. Thus, 
the advantages of piezosurgery could be useful.  
The piezosurgery is used in a variety of oral 
surgical procedures and has therapeutic advantages 
that include: more accurate, selective and safe cut 
(specially for causing less damage to the osteocytes), 
a cleaner operative field due to the attached oral 
irrigation and preservation of important structures 
like nerves and membranes [2].
The effects of this instrument use in cell viability 
are essential to bone regeneration [2]. Gulnahar’s 
et al. [4] study evaluated a conventional technique 
versus piezosurgery in third molar extractions 
impacted through the measurement of heat-shock 
protein 70 (Hsp 70). This protein signalize the 
intensity of the stress and injury to the tissue and 
is induced to keep the homeostasis under stress 
conditions. In the conventional technique the 
expression of Hsp 70 was twice that of piezosurgery. 
Besides that, the piezo cut of the bone tissue is 
more accurate and promotes less bleeding, and that 
reduces the stress in the alveolar bone and can 
help the function of repair cells postoperatively. In 
addition to this, cell viability, bone deposition and 
remodeling after osteotomy seems to be better with 
piezosurgery compared to conventional drills [9]. 
In the aspects related to the orthognathic surgery 
using piezosurgery, osteotomies had reduced blood 
loss and fewer lesions in the inferior alveolar nerve, 
with no need of extra invested time [8].
Rashad et al. [12] showed a limitation of 
piezosurgery: the preparation of the implant 
placements take longer and generates higher 
temperatures in the bone compared to conventional 
technique. Tsai et al. [16] outlined that, in third 
molars extraction, regarding recovery of the 
initial wound and bone healing, when compared 
piezosurgery and conventional techniques, no 
significant differences between both was found.
In a series of 9 cases of MRONJ treated with 
piezosurgery, with an one year follow-up, there was 
complete resolution in all cases after 2 weeks of the 
procedure, with no signs or symptoms of recurrence. 
This suggests that piezosurgery combined with 
antibiotic therapy can lead to the cure of MRONJ. 
The application of ultrasonic vibrations and powerful 
cavitation associated with the medical treatment, 
can reduce the quantity of microorganisms around 
the affected bone. According to previous reports, 
low frequency sound waves would be capable of 
erradicating more than 85% of the bacterias in the 
biofilm, when applied simultaneously with the use of 
antibiotics, for 3 species of clinical relevance: E. coli, 
S. epidermidis and Pseudomonas aeruginosa [1].
More randomized clinical studies of patients 
undergoing the same treatment modality are 
necessary for a recommendation based in stronger 
evidence. But, the positive results encourage future in 
vivo studies to possibly suggest a surgical treatment 
protocol of MRONJ which includes piezosurgery. 
Conclusion 
The management of patients with MRONJ 
involves the awareness about the clinical staging 
of the disease according to AAOMS consensus. 
The piezosurgery choice as a method to minimize 
surgical trauma was shown an efficient method for 
MRONJ resolution and disease control in a follow up 
of 24 months. More studies are necessary to create 
a protocol that includes this method of treatment.
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